A5082724437- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Coronary Interventions and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Central Venous Catheters and Hemodialysis
- Stress Responses and Cortisol
- Vascular Procedures and Complications
- Immune Response and Inflammation
- Cardiac Imaging and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Immune Cell Function and Interaction
Ospedale San Giovanni Bosco
2019-2020
University of Turin
2016-2019
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2016-2018
Ospedale San Luigi Gonzaga
2016
Sapienza University of Rome
2016
Saint Luke's Hospital
2016
Ospedale di Rivoli
2016
Istituto Nazionale di Riposo e Cura per Anziani
1991
There are limited data regarding the impact of final kissing balloon (FKI) in patients treated with percutaneous coronary intervention using ultrathin stents left main or bifurcations.All undergoing bifurcations enrolled RAIN registry (Very Thin Stents for Patients With MAIN BiF Real Life: The RAIN, a Multicenter Study) evaluating were included. Major adverse cardiac event (a composite all-cause death, myocardial infarction, target lesion revascularization, and stent thrombosis) was primary...
Aspirin is an irreversible and non-selective inhibitor of cyclo-oxygenase. It represents the cornerstone antiplatelet therapy used in secondary prevention cardiovascular disease. Disagreement over optimal maintenance dosage still exists; America Europe most doses aspirin are 81 mg 100 daily, respectively. There also debate on formulation route administration loading dose. The latest studies advise chewable non-enteric coated aspirin; intravenous alternative for unconscious or shocked...
Vessel Plus is an open acccess journal, which publishes articles related to vascular diseases, including acute respiratory distress syndrome, aneurysm, atherosclerosis, hypertension, stroke, peripheral or pulmonary etc.
Abstract Objectives Evaluate safety and efficacy of polymer‐free biolimus‐eluting stents (PF‐BESs) versus ultrathin in unprotected left main (ULM) or bifurcation. Background PF‐BESs due to reduced length dual antiplatelet therapy (DAPT) are increasingly used. However, there limited data about for ULM Methods We selected all‐patients treated bifurcation from two multicenter real life registries (RAIN [NCT03544294] evaluating stents, CHANCE [NCT03622203] appraising PF‐BES). After propensity...